Nishadil
Signup Signin
Delhi | 25°C (windy)
Beyond the Horizon: Can Survodirsen Rewrite the Future for NASH Cirrhosis?

Beyond the Horizon: Can Survodirsen Rewrite the Future for NASH Cirrhosis?
Beyond the Ache: When Swollen Feet Whisper a Deeper Story

Beyond the Ache: When Swollen Feet Whisper a Deeper Story
A New Dawn for Hepatitis B? Brii Biosciences Unveils Promising Cure Data

A New Dawn for Hepatitis B? Brii Biosciences Unveils Promising Cure Data
Beyond the Horizon: How Seladelpar is Reshaping Hope for PBC Patients

Beyond the Horizon: How Seladelpar is Reshaping Hope for PBC Patients
The Unfolding Story of the Liver: Francis Collins's Vision for a Healthier Future

The Unfolding Story of the Liver: Francis Collins's Vision for a Healthier Future
The Silent Scourge No More? A New Dawn in the Battle Against Hepatitis B

The Silent Scourge No More? A New Dawn in the Battle Against Hepatitis B
The Quiet Revolution: Could WVE-007 Be the Game Changer for AATD?

The Quiet Revolution: Could WVE-007 Be the Game Changer for AATD?
The Silent Scourge: Unmasking India's Fatty Liver Crisis Before It's Too Late

The Silent Scourge: Unmasking India's Fatty Liver Crisis Before It's Too Late
A Glimmer of Hope in the MASH Labyrinth: Sagimet's Denifanstat Shines

A Glimmer of Hope in the MASH Labyrinth: Sagimet's Denifanstat Shines
Unlocking Health: India's Gut Microbiome Revolution

Unlocking Health: India's Gut Microbiome Revolution
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
Beyond the Buzz: Unveiling the Hidden Liver Risks of Your Favorite Sweet Sips

Beyond the Buzz: Unveiling the Hidden Liver Risks of Your Favorite Sweet Sips
The Silent Killer: Why High Blood Pressure Poses a Greater Threat Than Diabetes in Fatty Liver Disease

The Silent Killer: Why High Blood Pressure Poses a Greater Threat Than Diabetes in Fatty Liver Disease
The Silent Threat Within: How Common Fatty Liver Transforms into a Deadly Disease

The Silent Threat Within: How Common Fatty Liver Transforms into a Deadly Disease
The Hepatitis B Vaccine Debate: Unpacking the Science, Safety, and Personal Choice

The Hepatitis B Vaccine Debate: Unpacking the Science, Safety, and Personal Choice
Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment

Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment
The Silent Scourge: How Alcohol Fuels a Global Liver Disease Epidemic

The Silent Scourge: How Alcohol Fuels a Global Liver Disease Epidemic
Hepatitis: India's Silent Epidemic and The Race Against Time

Hepatitis: India's Silent Epidemic and The Race Against Time
Your Fingernails: Tiny Windows to Your Inner Health – Don't Ignore the Signs!

Your Fingernails: Tiny Windows to Your Inner Health – Don't Ignore the Signs!
Unveiling the Hidden Enemy: Groundbreaking Study Exposes Alcohol's Deepest Liver Secrets

Unveiling the Hidden Enemy: Groundbreaking Study Exposes Alcohol's Deepest Liver Secrets
Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape

Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape
Your Liver: The Silent Guardian Working Overtime

Your Liver: The Silent Guardian Working Overtime
Beyond Swelling: What Your Puffy Feet Could Be Telling You About Your Health

Beyond Swelling: What Your Puffy Feet Could Be Telling You About Your Health
Groundbreaking Trial: ION224 Shows Remarkable Promise in Combating MASH Liver Inflammation

Groundbreaking Trial: ION224 Shows Remarkable Promise in Combating MASH Liver Inflammation
Beyond Diet and Weight: Unveiling the Gut's Secret Link to Diabetes and Liver Disease

Beyond Diet and Weight: Unveiling the Gut's Secret Link to Diabetes and Liver Disease
Your Nails Speak Volumes: Decoding 10 Critical Health Signals

Your Nails Speak Volumes: Decoding 10 Critical Health Signals
Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success

Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success
Unveiling the Hidden Trap: How Alcohol Stalls Liver Regeneration

Unveiling the Hidden Trap: How Alcohol Stalls Liver Regeneration
Revolutionizing Early Diagnosis: A New Dawn for Alpha-1 Patients

Revolutionizing Early Diagnosis: A New Dawn for Alpha-1 Patients
A New Dawn for Liver Health: FDA Greenlights Revolutionary MASH Treatment

A New Dawn for Liver Health: FDA Greenlights Revolutionary MASH Treatment
Load more..